Treatment of liver fibrosis in hepatolenticular degeneration with traditional Chinese medicine: systematic review of meta-analysis, network pharmacology and molecular dynamics simulation.
Wilson's disease
hepatolenticular degeneration
liver fibrosis
meta-analysis
molecular dynamics simulation
network pharmacology
traditional Chinese medicine
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2023
2023
Historique:
received:
24
03
2023
accepted:
18
04
2023
medline:
30
5
2023
pubmed:
30
5
2023
entrez:
30
5
2023
Statut:
epublish
Résumé
Traditional Chinese medicine (TCM) is widely used in the clinical treatment of hepatolenticular degeneration (HLD) and liver fibrosis (LF). In the present study, the curative effect was assessed using meta-analysis. The possible mechanism of TCM against LF in HLD was investigated using network pharmacology and molecular dynamics simulation. For literature collection, we searched several databases, including PubMed, Embase, Cochrane Library, Web of Science, Chinese National Knowledge Infrastructure (CNKI), VIP Database for Chinese Technical Periodicals (VIP) and Wan Fang database until February 2023, and the Review Manager 5.3 was used to analyze the data. Network pharmacology and molecular dynamics simulation were used to explore the mechanism of TCM in treating LF in HLD. The results of the meta-analysis revealed that the addition of Chinese herbal medicine (CHM) in treating HLD resulted in a higher total clinical effective rate than western medicine alone [RR 1.25, 95% CI (1.09, 1.44), Meta-analysis indicates that TCM is beneficial in treating HLD patients and improving LF. The present study successfully predicts the effective components and potential targets and pathways involved in treating LF for the three high-frequency CHMs of DH-HL-JH. The findings of the present study are hoped to provide some evidence support for clinical treatment. https://www.crd.york.ac.uk/PROSPERO, identifier: CRD42022302374.
Sections du résumé
Background
UNASSIGNED
Traditional Chinese medicine (TCM) is widely used in the clinical treatment of hepatolenticular degeneration (HLD) and liver fibrosis (LF). In the present study, the curative effect was assessed using meta-analysis. The possible mechanism of TCM against LF in HLD was investigated using network pharmacology and molecular dynamics simulation.
Methods
UNASSIGNED
For literature collection, we searched several databases, including PubMed, Embase, Cochrane Library, Web of Science, Chinese National Knowledge Infrastructure (CNKI), VIP Database for Chinese Technical Periodicals (VIP) and Wan Fang database until February 2023, and the Review Manager 5.3 was used to analyze the data. Network pharmacology and molecular dynamics simulation were used to explore the mechanism of TCM in treating LF in HLD.
Results
UNASSIGNED
The results of the meta-analysis revealed that the addition of Chinese herbal medicine (CHM) in treating HLD resulted in a higher total clinical effective rate than western medicine alone [RR 1.25, 95% CI (1.09, 1.44),
Conclusion
UNASSIGNED
Meta-analysis indicates that TCM is beneficial in treating HLD patients and improving LF. The present study successfully predicts the effective components and potential targets and pathways involved in treating LF for the three high-frequency CHMs of DH-HL-JH. The findings of the present study are hoped to provide some evidence support for clinical treatment.
Systematic review registration
UNASSIGNED
https://www.crd.york.ac.uk/PROSPERO, identifier: CRD42022302374.
Identifiants
pubmed: 37250630
doi: 10.3389/fmed.2023.1193132
pmc: PMC10213944
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
1193132Informations de copyright
Copyright © 2023 Yang, Wang, Tang, Shao, Gao and Wu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Hepatology. 2008 Jun;47(6):2089-111
pubmed: 18506894
Nucleic Acids Res. 2021 Jan 8;49(D1):D1388-D1395
pubmed: 33151290
Redox Biol. 2020 Sep;36:101600
pubmed: 32526690
Front Pharmacol. 2016 Aug 17;7:247
pubmed: 27582705
J Diabetes Res. 2021 May 28;2021:9941791
pubmed: 34159207
Parkinsonism Relat Disord. 2010 Dec;16(10):639-44
pubmed: 20708958
Gut. 2002 Jun;50(6):891-6
pubmed: 12010897
Nucleic Acids Res. 2019 Jul 2;47(W1):W357-W364
pubmed: 31106366
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
J Inorg Biochem. 2019 Apr;193:106-111
pubmed: 30703747
Appl Clin Genet. 2017 Jan 13;10:9-19
pubmed: 28144156
Nat Rev Dis Primers. 2018 Sep 6;4(1):21
pubmed: 30190489
Nat Methods. 2012 Nov;9(11):1069-76
pubmed: 23132118
Front Pharmacol. 2021 Apr 29;12:683613
pubmed: 33995112
BMC Neurol. 2019 Nov 12;19(1):278
pubmed: 31718567
Front Biosci. 2002 Apr 01;7:d808-26
pubmed: 11897564
Mol Immunol. 2017 Jan;81:160-172
pubmed: 27978490
Curr Protoc Bioinformatics. 2016 Jun 20;54:1.30.1-1.30.33
pubmed: 27322403
J Cell Mol Med. 2014 Jul;18(7):1392-406
pubmed: 24779927
Oxid Med Cell Longev. 2020 Dec 30;2020:8825387
pubmed: 33488935
Cells. 2020 Feb 27;9(3):
pubmed: 32120837
Zhongguo Zhong Yao Za Zhi. 2021 May;46(10):2424-2433
pubmed: 34047086
J Nat Med. 2009 Oct;63(4):415-20
pubmed: 19554395
J Huazhong Univ Sci Technolog Med Sci. 2013 Feb;33(1):75-80
pubmed: 23392711
Database (Oxford). 2019 Jan 1;2019:
pubmed: 30951143
Antioxidants (Basel). 2022 Sep 27;11(10):
pubmed: 36290632
Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98
pubmed: 25428349
Acta Pharmacol Sin. 2002 Aug;23(8):739-44
pubmed: 12147197
Adv Exp Med Biol. 2021;1291:15-39
pubmed: 34331682
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000 Dec;20(12):890-2
pubmed: 11938856
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Toxicol Ind Health. 2016 Jul;32(7):1224-36
pubmed: 25415873
Cells. 2019 Oct 29;8(11):
pubmed: 31671832
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489
pubmed: 33237286
J Hepatol. 2012 Mar;56(3):671-85
pubmed: 22340672
Evid Based Complement Alternat Med. 2021 Aug 17;2021:4582412
pubmed: 34457021
J Cheminform. 2014 Apr 16;6:13
pubmed: 24735618
Sci Rep. 2017 Aug 24;7(1):9289
pubmed: 28839277
Zhongguo Zhong Yao Za Zhi. 2022 Jan;47(1):176-187
pubmed: 35178925
Phytomedicine. 2021 May;85:153550
pubmed: 33831691
Phytother Res. 2022 Oct;36(10):3774-3791
pubmed: 35918855